Background {#Sec1}
==========

Rapid molecular typing of bacterial pathogens is critical for public health epidemiology, surveillance and infection control \[[@CR1],[@CR2]\]. Two key goals of such activities are: (1) to detect the presence of genes linked to clinically relevant phenotypes - including virulence genes, antimicrobial resistance genes or serotype determinants; and (2) to classify isolates into clonal groups, via multi-locus sequence typing (MLST \[[@CR3]\]) or detection of clone-specific or other epidemiological markers. Whole genome sequencing (WGS) or 'genomic epidemiology' is increasingly being adopted for these tasks and has the potential to replace current techniques which are mainly based on PCR and/or restriction enzyme digestion coupled with sequencing or size separation via electrophoresis \[[@CR1],[@CR4]\]. WGS is particularly attractive as: (1) it can be applied simultaneously to large numbers of bacterial isolates of any species with no need for organism- or target-specific reagents; and (2) the resulting data are readily shareable, can be compared easily with past and future data sets, and are informative for both routine surveillance (monitoring genes and clones) and detailed outbreak investigation (genome-wide phylogenies for transmission analysis) \[[@CR2],[@CR4]\].

WGS has revolutionised pathogen research, and its potential to revolutionise the practice of public health epidemiology, surveillance and infection control has been recognised for some time \[[@CR4]-[@CR10]\]. Despite the enthusiasm and several demonstration studies \[[@CR11]-[@CR16]\], the routine use of WGS poses significant challenges for public health and diagnostic laboratories, foremost of which is a lack of solutions for the rapid and reproducible extraction of informative, interpretable and shareable data from raw sequence data \[[@CR1],[@CR17]\].

Currently available methods rely on assembling short reads into longer contiguous sequences (contigs), which can be interrogated using BLAST or other search algorithms to identify genes or alleles of interest (for example, ARG-Annot \[[@CR18]\]; ResFinder, PlasmidFinder and MLST typer \[[@CR19]-[@CR21]\]; BIGSdb \[[@CR22],[@CR23]\]). The reliance on assembly introduces efficiency and sensitivity problems due to the data, time and computational requirements for generating high quality assemblies of bacterial genomes from short reads. There are several assemblers (for example, *Velvet* \[[@CR24]\], *SPAdes* \[[@CR25]\]) that can produce a bacterial genome assembly in minutes to hours with a few gigabytes of memory. However, the production of high quality assemblies with these tools requires quality filtering and other preprocessing of reads as well as optimisation of kmer length and other parameters which in practice requires several alternative assemblies to be generated and compared \[[@CR26],[@CR27]\], thus multiplying by an order of magnitude the amount of computational time and memory required to produce each genome prior to typing analysis. Further, the quality of even highly optimised assemblies remains highly variable, even for closely related genomes sequenced together in multiplex. Hence assembly-based analyses of genomes sequenced with short-read technology are very difficult to standardise and quality control, which is important to ensure robust, reliable and reproducible assays for use in public health and infection control.

Here we describe a new tool for genomic epidemiology, SRST2, which performs fast and accurate detection of genes and alleles direct from WGS short sequencing reads. SRST2 can type reads using any sequence database(s) and can calculate combinatorial sequence types defined in MLST-style databases \[[@CR3]\]. We demonstrate its utility for routine molecular typing in public health and hospital laboratories via automated MLST and typing of virulence, antimicrobial resistance and plasmid genes. SRST2 is named after our earlier tool SRST (Short Read Sequencing Typing) which performed MLST on short reads \[[@CR28]\], however the SRST2 code is entirely novel and uses different read mapping, scoring and reporting algorithms to SRST, is more stable and robust, and is designed for gene detection and allele typing as well as MLST.

Implementation {#Sec2}
--------------

Given a read set and database of reference allele sequences, SRST2 is designed to perform two key tasks: (1) detect the presence of a gene or locus; and (2) determine the precise or closest matching allele for that locus, among a set of possible reference allele sequences. The approach is illustrated in Figure [1](#Fig1){ref-type="fig"}. A database of reference sequences must be provided in fasta format, in which the fasta headers indicate both the locus (so that alleles of the same locus can be compared) and a unique name for each allele. In the case of MLST data an additional database of ST profiles is provided as tab-delimited text, which assigns STs to unique combinations of alleles. Current MLST data (allele sequences and profile definitions) can be downloaded from pubmlst.org automatically using the *getmlst.py* script supplied with SRST2. For most MLST schemes, these files are compatible with SRST2 and can be used without modification. Improperly formatted databases, or other private sequence databases, can be easily formatted for use with SRST2 using the scripts supplied with the program. Any number of sequence databases can be analysed in a single run, allowing for simultaneous typing of MLST, resistance genes and virulence genes.Figure 1**Summary of SRST2 approach.** Inputs are reads (fastq format) and one or more databases of reference allele sequences for typing (fasta format). Reads are aligned to all reference sequences (using *bowtie2*) and each alignment processed (using *SAMtools*). At each position in each alignment, the number of matching and mismatching bases is determined and a binomial test is performed to assess the evidence against the reference allele; resulting in a set of *P* values for each reference allele sequence. To determine which of all known reference alleles is most likely present at a given locus, the *P* value distributions for known alleles are compared as described in the text. Briefly, for each allele the *P* values expected if the reads were derived from the reference allele in the presence of a given level of sequencing error (set to 1% of bases by default) are regressed on those actually observed, similar to a Q-Q plot; the slope of the fitted line, which increases with the strength of evidence against the reference allele, is calculated and taken as the score for that allele. The scores file (optional output) contains the scores for each allele at each locus, along with additional information about the alignments for each allele including percent coverage. For each locus, the allele with the lowest score is accepted as the closest matching allele (small arrows) and reported in the output table. In MLST mode, sequence type (ST) definitions are provided as input and used by SRST2 to calculate STs for each read set.

For each input database, reads are aligned using *bowtie2* \[[@CR29]\] v2.1.0 or above with the '\--very-sensitive-local' and '-a' settings, and all alignments are reported to a file in SAM format. Mapping sensitivity can be fine-tuned by specifying to SRST2 any of the parameters available within the *bowtie2-align* command or a maximum number of mismatches per read (default 10 mismatches allowed). Flags in the resulting SAM file are modified so that each read is included in the pileup for every allele to which it is aligned. Pileups are generated using *SAMtools* v0.1.18 \[[@CR30]\] *mpileup* and parsed by SRST2 to determine percent coverage, divergence, and mismatches as well as to calculate a score for each possible allele.

Allele scoring {#Sec3}
--------------

An overview of the scoring approach is given in Figure [1](#Fig1){ref-type="fig"}. We begin with an alignment of reads from sample *s* to a reference sequence *r*. At each position *i* in the reference sequence *r* (*r*~*i*~), let *s*~*i*~ be the set of reads in sample *s* that align to *r*~*i*~. Let *a*~*i*~ be the total number of reads in *s*~*i*~, and let *b*~*i*~ be the number of reads in *s*~*i*~ in which the aligned base does not match the reference base at *r*~*i*~. If sample *s* contains the precise sequence *r*, then the probability of a mismatched base at any position in an aligned read is equal to the per-base error rate of the sequencing technology *e*~*i*~, which for Illumina is taken to be 0.01, although this can vary depending on what preprocessing steps are implemented \[[@CR31],[@CR32]\].

To quantify the evidence against the presence of the reference sequence *r* in *s*, we perform a Binomial test at each position *r*~*i*~, to generate a one-sided *P* value *P*~*i*~ to assess the probability of observing *a*~*i*~-*b*~*i*~ successes in *a*~*i*~ trials, with a probability of success of 1-*e*~*i*~. Any change at position *r*~*i*~ - including a base substitution, an insertion of any size or a deleted base - is treated as a mismatch, incrementing *b*~*i*~ by 1. For large deletions that result in an absence of any aligned reads (including truncations of the end of the sequence), *a*~*i*~ = 0 and no binomial test is possible. In this case, the evidence for the deletion is provided by the reads which align adjacent to the deletion but do not align across the deletion. Hence we calculate the average number of reads aligned to the two bases preceding the deletion, *d*~*i*~, and conduct the binomial test with *a*~*i*~ = *b*~*i*~ = *d*~*i*~.

We then utilise a non-parametric approach to score each allele by considering the set of all *P* values calculated for reference sequence *r*. First, to minimise artefacts associated with fluctuation in read depths, we (a) set *P*~*i*~ = 1 where *b*~*i*~ = 0, and weight *P*~*i*~ by the relative read depth (that is, weight of evidence) at position *r*~*i*~ compared to those of other positions in *r*:$$\documentclass[12pt]{minimal}
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We then compare the sorted -log~10~(*P*~*i*~) values versus those of the theoretical distribution of -log~10~(*x*~*j*~/n) where n = length(*r*) and *x*~*j*~*=* 1,2,...n, analogous to a quantile-quantile (QQ) plot (Figure [1](#Fig1){ref-type="fig"}). A linear model is fitted to the two probability distributions and the resulting slope is taken as the score for reference sequence *r*, *score*~*r*~. Here we leverage a common criticism of linear models to our advantage: the susceptibility to outliers at the tails of the distribution. In this case, outliers are typically SNPs or indels relative to the sequence *r* which, because they result in low *P* values in the binomial test and thus very high values of -log~10~(P), are at the end of the observed distribution (Figure [1](#Fig1){ref-type="fig"}). Thus when a linear model is fitted, its slope increases with the number of well-supported SNPs and indels compared to the reference. As a result, among reference alleles of the same locus, the sequence *r* with the lowest *score*~*r*~ (flattest slope in the QQ plot) is the most likely match for sample *s*.

Reporting outputs {#Sec4}
-----------------

For each sample *s* and each locus or gene cluster, SRST2 output tables report the lowest scoring allele sequence *r*, the average read depth of *s* across *r* and indicators of any evidence against a precise match with *r* (including mismatches supported by \>50% of aligned reads, or read depth falling below a cutoff). Only matches passing the user-set coverage and divergence cutoffs (by default, \>90% coverage and \<10% divergence) are reported. For MLST data, STs are calculated according to the MLST profiles database provided, based on the closest matching alleles at each locus.

Normally, an exact match between *r* and *s* would be assigned if (a) *r* has the lowest *score*~*r*~ among the set of alleles of the same locus or gene cluster, and (b) there are no SNPs or indels between *r* and *s*. If (a) holds but (b) does not, this is indicative of a novel allele and SRST2 will flag the result in output tables. In such cases, we recommend that users who are interested in defining novel alleles should inspect the raw sequence data (which may be assisted by the alignments, pileups and consensus fastq files generated by SRST2).

Optionally, SRST2 can report the full details of scoring *s* against all reference sequences *r*, to enable users to parse and interpret the results to suit specific needs. These include average depth of *s* across *r*, average depth across the first and last two bases of *r*, the number of positions in *r* in which the majority of aligned reads in *s* show a mismatch against *r* (with SNPs, insertion/deletions and truncations reported separately), the depth of bases neighbouring truncations and, for the position with the greatest proportion of mismatching reads, the total aligned reads, total mismatching, proportion mismatching, and binomial *P* value.

Major differences between SRST and SRST2 {#Sec5}
----------------------------------------

SRST2 is new code and takes an entirely different approach to read mapping, scoring alignments and reporting results than SRST \[[@CR28]\], which was designed solely for MLST and is unsuitable for detection of acquired genes. In SRST, *bwa* was used for global alignment of reads to MLST loci and their flanking sequences; in SRST2, *bowtie2* is used for local alignment of reads to any locus, without need for flanking sequences, allowing detection of acquired genes as well as MLST. SRST scores were calculated in an entirely different way and were not designed to take into account deletions/truncations or the relative weight of evidence provided by each position in the alignment (differences in read depth). SRST2 allows finer control of mapping and scoring parameters and provides more detailed reports than SRST. SRST2 is also faster (2 to 5×) and slightly more reliable than SRST for MLST analysis (see below).

Methods {#Sec6}
=======

Bacterial isolates and sequencing {#Sec7}
---------------------------------

A total of 231 *Listeria monocytogenes* isolates were analysed in this study, at the Microbiological Diagnostic Unit (MDU) Public Health Laboratory in Victoria, Australia. MDU is the national reference laboratory for *L. monocytogenes* and the isolates analysed include several from recent outbreaks as well as from the laboratory's reference collection. Ethical approval was not required for the use of reference laboratory isolates in this project. Cultures of *L. monocytogenes* isolated from food, environmental or clinical specimens were purified by two successive single colony selections after streaking onto horse blood agar (HBA) incubated for 18 to 24 h at 37°C. Resultant bacterial growth on the surface of HBA medium was aseptically collected and resuspended in a cryotube (Nalgene) containing 1 mL of sterile glycerol storage broth (1.6% w/v Tryptone, Oxoid Pty Ltd, LP0042 containing 20% v/v glycerol) prior to storage at -70°C. Cultures were retrieved from storage as required and freshly grown (HBA, 18 to 24 h at 37°C) in preparation for DNA extraction. DNA was extracted from each isolate using QIAmp DNA Mini Kit (Qiagen) and eluted in EB buffer (Qiagen) (Tris buffer, no EDTA).

DNA samples were subjected to traditional *L. monocytogenes* MLST analysis \[[@CR33],[@CR34]\], with a minor modification to the annealing temperature for the *bglA* PCR (52°C not 45°C). The PCR products were purified with FastAP Thermosensitive Alkaline Phosphatase (Thermo Scientific) and Exonuclease I (Thermo Scientific). The purified PCR products were sequenced using BigDye Terminator v3 chemistry followed by capillary sequencing using a 3130xL Genetic Analyzer (Applied Biosystems). Trace analysis was conducted using BioNumerics version 6.6 with MLST Online plugin version 2.13 and Batch Sequence Assembly plugin version 1.34.

DNA was subjected to multiplex library preparation using Nextera XT followed by sequencing using an Illumina MiSeq. DNA was quantified by Qubit dsDNA HS Assay Kit (Invitrogen) and normalised to 0.2 ng/μL. Total 1 ng of DNA was used for Nextera XT DNA Sample Preparation Kit (Illumina). Tagmentation of genomic DNA, PCR amplification with dual index primers, PCR clean-up using Agencourt AMPure XP (Beckman Coulter), DNA libraries normalization, library pooling and MiSeq sample loading were performed according to the manufacturer's instruction with minor modifications. For longer than 2 × 250 bp runs on the MiSeq, 25 μL of AMPure XP beads was added to each PCR-amplified product during the PCR purification step otherwise 30 μL of AMPure XP beads was added. For some samples, after PCR purification, DNA fragment size and library concentration was analysed by 2100 Bioanalyzer (Agilent Technologies) and Qubit dsDNA HS Assay Kit (Invitrogen). DNA libraries were normalized manually to 4 nM and libraries with unique indexes were pooled in equal volumes. Each resulting pooled library was denatured and diluted with 0.2 N NaOH and pre-chilled HT1 (Illumina) to produce a 20 pM denatured library in 1 mM NaOH. Prior to the MiSeq run, the denatured library was further diluted with pre-chilled HT1 to approximately 12 to 13.5 pM. A total of 600 μL of library including 2% (v/v) 20 pM denatured PhiX library (Illumina) was loaded together with MiSeq reagent kit v3 (Illumina) according to the manufacturer's instructions.

Publicly available short read data used in this study {#Sec8}
-----------------------------------------------------

Details of Illumina read sets used in this study are provided in Table [1](#Tab1){ref-type="table"} and Table [2](#Tab2){ref-type="table"}. Data tables specifying the expected STs of each read set, summarised from published papers, are given in Additional file [1](#MOESM1){ref-type="media"} \[[@CR35]\].Table 1**Data sets used to assess accuracy of SRST2SpeciesCitationN (isolates)PopulationSequencing centreAverage read depthRead length (bp)***Staphylococcus aureus*\[[@CR36]\]134Clonal, ST22Sanger, UK24×55*Staphylococcus aureus*\[[@CR37]\]128Clonal, ST239Sanger, UK60×65*Streptococcus pneumoniae*\[[@CR38]\]113Clonal, ST81Sanger, UK30×55*Salmonella enterica* Typhimurium\[[@CR39]\]44Clonal, ST313Sanger, UK34×76*Shigella (E. coli)*\[[@CR40]\]81Clonal, *S. sonnei*Sanger, UK25×55*Enterococcus faecium*\[[@CR41]\]43Diverse, dominated by ST203, ST17Melbourne, Australia658×101*Listeria monocytogenes*This paper231DiverseMelbourne, Australia36×152Table 2**Data sets used to demonstrate utility of SRST2 in the hospital settingSpeciesCitationN (isolates)Average read depthRead length (bp)***Enterococcus faecium* (Figure [7](#Fig7){ref-type="fig"}a-c)\[[@CR41]\]43658×101*Hospital outbreak investigations* (Figure [8](#Fig8){ref-type="fig"}a-b)\[[@CR15]\]2036×151*K. pneumoniae*, *E. coli*\[[@CR42]\]69, 7434×101

Subsampling of read sets {#Sec9}
------------------------

To explore accuracy at low read depths, 10 genomes each of *S. aureus* and *E. faecium* were selected for random subsampling of reads to simulate genomes sequenced to low read depth. To do this, we used the mean read depth across MLST loci to calculate the sampling fraction required to achieve approximately 1×, 2×, ... 10× mean read depth. We randomly sampled reads from the forward reads file at the required sampling fraction, and extracted the corresponding reverse reads, using Perl scripts. Ten random samples were generated from each read set at each depth level, generating a total of 1,000 read sets for each species.

Sequence databases used in this study {#Sec10}
-------------------------------------

MLST databases for *Staphylococcus aureus*, *Streptococcus pneumoniae*, *Salmonella enterica*, *Escherichia coli*, *Enterococcus faecium*, *Listeria monocytogenes* and *Enterobacter cloaceae* were downloaded from pubmlst.org using the *getmlst.py* script included with SRST2 (June 2014).

Antimicrobial resistance gene detection was performed using the ARG-Annot database of acquired resistance genes \[[@CR18]\]. Allele sequences (DNA) were downloaded in fasta format \[[@CR43]\] (May, 2014). Sequences were clustered into gene groups with ≥80% identity using CD-hit \[[@CR44]\] and the headers formatted for use with SRST2 using the scripts provided (*cdhit_to_csv.py*, *csv_to_gene_db.py*). A copy of the formatted sequence database used in this study is included in the SRST2 github repository \[[@CR35]\].

Representative sequences for 18 plasmid replicons were extracted from GenBank using the accessions and primer sequences specified by Carattoli *et al.* \[[@CR45]\]. A copy of the formatted sequence database used in this study is included in the SRST2 github repository \[[@CR35]\].

Simulation of expanded S. aureus MLST database {#Sec11}
----------------------------------------------

As more genomes are sequenced and as bacteria continue to evolve, novel alleles will continue to be discovered and thus the size of allele databases will increase. To explore the impact of database size on accuracy of allele detection with SRST2, we simulated expansion of the current *S. aureus* MLST database from 2,161 alleles (mean 309 per locus) to 5,578 alleles (mean 797 per locus). The additional 500 alleles (approximately) per locus were generated using *netrecodon* v6.0.0 \[[@CR46]\]. Sequences derived from the true MLST database were used to seed the simulation at each locus as follows. Existing alleles were translation-aligned between start (alignment start) and stop (alignment end) codons, those containing a frameshift or stop codon were removed, and the modal consensus sequence was exported. The best-fit DNA substitution model of each true alignment was determined using the AIC in *MrModeltest* v2.3, as implemented in *PAUP\** v4.0b. In *netrecodon*, the modal sequences were forward evolved under the coalescent, using the parameters of the best-fitting model for each locus, mutation rate 1E-7 and recombination rate 1E-7/15 (based on reported r/m of 1/15 \[[@CR47]\]). A total of 100 independent replicates of forward evolution were performed per locus, retaining 2,000 sequences per replicate (N = 200,000 simulated sequences per locus). The first 500 unique simulated sequences at each locus were added to the MLST database, and duplicate sequences were removed.

Assembly-based analysis {#Sec12}
-----------------------

Assemblies were generated using the *de novo* assembler *Velvet* v1.2.10 \[[@CR24]\], with optimal kmer choice for each read set refined through iterative calls to *VelvetOptimiser* v2.2.5 \[[@CR48]\]. Briefly, each read set was assembled using a call to *VelvetOptimiser* with kmers from 29 up to 89, in steps of 12. The optimal kmer*,* k~1~, was extracted and a second call to *VelvetOptimiser* was made using kmers from k~1~-12 up to k~1~ + 12, in steps of 4. A final call to *VelvetOptimiser* was run using kmers from k~2~-4 up to k~2~ + 4, in steps of 2. The final assembly was that output from the third and final call to *VelvetOptimiser.*

For MLST analysis from assemblies, a nucleotide BLAST + (v2.2.25) search was performed for each locus and each contig set. In this BLAST search, the contig set was used to query the database containing all known allele sequences for a given locus, and the top BLAST hit was reported. If this hit had ≥90% nucleotide identity across ≥90% of the length of the reference allele sequence, an allele call was recorded. If the hit was an exact match to a known allele (that is, 100% nucleotide identity across 100% of the length of the allele sequence), this was considered a precise allele call. The Python code used is available within the SRST2 distribution. Where the hit was not an exact match (n = 42), an alternative nucleotide BLAST analysis was performed using the allele sequences as query and the contig set as database, and the results manually inspected to determine whether it was possible to identify the correct allele from the assembly. For gene detection analysis from assemblies, a nucleotide BLAST search was performed in which the set of reference sequences (sequence database, that is antimicrobial resistance gene database) was used to query the database of all contigs for that assembly.

SRST (v1) analysis {#Sec13}
------------------

The 543 read sets used for validation of SRST2 allele calling (Table [1](#Tab1){ref-type="table"}) were also analysed using SRST \[[@CR28]\], run with default settings.

Web-based analysis with MLST Typer and ResFinder {#Sec14}
------------------------------------------------

The 44 *S. enterica* read sets (Table [1](#Tab1){ref-type="table"}) were analysed using the MLST Typer \[[@CR21]\] and ResFinder \[[@CR19]\] websites. This data set was chosen to begin with as it is the smallest of those used for validation in the manuscript (n = 44). Each read set took 3 to 4 h to upload and analyse using these websites, and had to be done in serial as attempting to run multiple jobs crashed Java. Therefore it was not feasible to test all read sets for comparison.

MLST Typer was run using default settings and the *Salmonella enterica* MLST database. ResFinder cutoffs were set to \>90% identity, \>80% coverage (no \>90% cutoff was available), and 'all' AMR loci. To facilitate direct comparison with ResFinder, the *S. enterica* read sets were re-analysed with SRST2 using the ResFinder resistance gene sequence database downloaded from the ResFinder website (a copy of the SRST2-formatted ResFinder database is provided in the SRST2 distribution, along with the ARG-Annot resistance gene database which we recommend). All *S. enterica* Typhimurium carry a chromosomally encoded copy of *aac(6')-Iaa*, which is included in the ResFinder and ARG-Annot databases as it can occur as an acquired resistance gene in other organisms. Hence this provides a 'gold standard' estimate of gene detection and is reported separately to the acquired resistance genes for which no independent confirmation of gene presence/absence is available (Table [3](#Tab3){ref-type="table"}).Table 3**Comparison of SRST2 and ResFinder (ref 19) for detection of acquired resistance genesCorrect callsN (%)***Aac(6')-Iaa* (chromosomally encoded core gene, expect in all strains)Both methods35 (83%)SRST2 only7 (17%)ResFinder only0*Acquired resistance genes* (total 44 detected)Both methods24 (55%)SRST2 only20 (45%)ResFinder only042 *S. enterica* serovar Typhimurium read sets (accessions in Table [1](#Tab1){ref-type="table"}) with \>1× mean read depth were analysed using the ResFinder website, and also with SRST2 using the sequence database downloaded from the ResFinder website. Results are shown separately for the chromosomally encoded core resistance gene *aac(6')-Iaa*, which is expected to be in all strains, and horizontally acquired resistance genes.

Analysis runs and time calculations {#Sec15}
-----------------------------------

All SRST2, SRST, assembly and BLAST analysis was run on a Linux cluster (iDataplex × 86 system, 'Barcoo' cluster at VLSCI \[[@CR49]\]). SRST2 was run with default parameters. Details of *Velvet* assembly and BLAST analysis are given below. Run times were calculated from time stamps extracted from log files for SRST2 and *Velvet Optimiser* assembly runs.

Statistical analysis {#Sec16}
--------------------

All statistical analysis and data plotting was performed in *R*. Allele calling performance of SRST2 and assembly + BLAST was assessed via three metrics: (1) call rate = total number of allele calls made, for SRST2 this was a call with ≥90% coverage and no uncertainty recorded (that is, with ≥2× read depth at both ends and also neighbouring any truncations or deleted bases), for BLAST this was a call with ≥90% coverage and ≥90% nucleotide identity; (2) false positive rate = total number of correct allele calls as a proportion of all calls; and (3) proportion of all tests resulting in a call with a correct allele, equal to (call rate) \* (1 - (false positive rate)). As these metrics are proportions, the significance of differences in performance metrics was calculated using a two-sided test for equality of proportions (*prop.test* function in *R*). Resistance gene detection was assessed using a cutoff of ≥90% coverage and ≥90% identity to define the presence of a gene.

Results and discussion {#Sec17}
======================

Validation of allele calling {#Sec18}
----------------------------

To assess the accuracy of allele identification with SRST2, we analysed publicly available Illumina data from 543 bacterial genomes of five different species for which independent MLST data were available (Table [1](#Tab1){ref-type="table"}). With seven loci in each MLST scheme, this yielded 3,801 allele calls across 35 loci to assess call rate and false positive rate. The read sets represented a wide range of average read depths, with 90% in the range 12× - 130× and 50% between 20× - 60× (Table [1](#Tab1){ref-type="table"}). For each species, we used SRST2 to download the latest MLST database from pubmlst.org and subsequently ran SRST2 using default parameters. Median run time was 6 min per sample (interquartile range, 4 to 10 min) and increased linearly with number of reads (Figure [2](#Fig2){ref-type="fig"}). Efficiency can be easily improved or standardised, without data preprocessing, by instructing SRST2 to map the first N reads only.Figure 2**Run times for MLST analysis with SRST2.** Lines are linear regression of runtime on reads, calculated separately for each species from public data sets (details in Table [1](#Tab1){ref-type="table"}).

SRST2 call rates and true positive rates increased with average read depth, stabilizing with depths ≥15× (Figure [3](#Fig3){ref-type="fig"}a, Additional file [2](#MOESM2){ref-type="media"}). For comparison, we also assembled each read set using *Velvet* \[[@CR24]\] and *VelvetOptimiser* \[[@CR48]\] and used nucleotide BLAST to identify MLST alleles (assembly + BLAST method; [Methods](#Sec6){ref-type="sec"}). At read depths ≥15×, SRST2 made significantly more allele calls than assembly + BLAST (call rates 99.9% vs. 95.9%, respectively; *P* \<1 × 10^-15^), with equivalent accuracy (0.46% vs. 0.22% of allele calls incorrect; *P* = 0.16). The heuristic information provided by SRST2 (that is, confident mismatches, insertions, deletions or truncations reported from read mapping) was a strong indicator of accuracy in the result: where an exact match was reported (98% of calls with depth ≥15×), 0.2% of allele calls were incorrect; where an inexact match was reported, 11.7% of allele calls were incorrect. Hence, the key difference between the two methods was the ability of SRST2 to make correct calls where assembly + BLAST could not make any call: for read depths ≥15×, SRST2 made a call with the correct allele 99.4% of the time, compared to only 95.7% for assembly analysis (*P* \<1 × 10^-15^ for difference in frequencies of correct allele calls). At sequence type (ST) level, the difference was even greater: SRST2 achieved accurate ST assignment for 98% of isolates with average depth ≥15×, whereas assembly + BLAST correctly identified only 79%. SRST2 also performed better than SRST and the MLST typer website (which implements an alternative assembly + blast approach), see Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}.Figure 3**Overall accuracy of SRST2 allele calling and gene detection. (a)** MLST analysis of public data from five species (N = 543 genomes, 3,801 loci, details Additional file [1](#MOESM1){ref-type="media"}: Table S1). Tests were grouped by read depth and accuracy rates (left y-axis, correct allele calls as a proportion of tests), calculated at each depth (x-axis, red slashes indicate scale change). Grey bars, number of tests at each depth (right y-axis); Lines, accuracy of allele calling. **(b)** MLST analysis of *Listeria monocytogenes* data (N = 231 genomes, 1,671 loci) conducted in a public health laboratory; colours and axes as in (a). **(c)** Accuracy of *vanB* resistance gene detection for *E. faecium* read sets subsampled to low depth; y-axis shows proportion of correct (presence vs. absence) calls as a proportion of 100 tests at each depth; colours and axes as in (a). A call of 'present' implies detection of ≥90% of the length of the gene at ≥90% nucleotide identity.Table 4**Comparison of SRST2 and SRST (v1, ref 28)Correct callsN (%)**Both491 (90.4%)Neither18 (3.3%)SRST2 only21 (4%)SRST (v1) only13 (2.4%)Summary of correctly called MLST sequence types (STs) for 543 bacterial isolates from five species (data set detailed in Table [1](#Tab1){ref-type="table"}).Table 5**Comparison of SRST2 and MLST Typer (ref 21)Correct callsN (%)**Both14 (33%)Neither1 (2%)^a^SRST2 only27 (61%)MLST Typer only0Summary of correctly called MLST sequence types (STs) for 42 *S. enterica* serovar Typhimurium read sets (accessions in Table [1](#Tab1){ref-type="table"}) with \>1× mean read depth.^a^ERR023807 had 44× read depth and was not called by MLST Typer, but six/seven alleles were correctly called by SRST2.

To assess performance at low read depths (≤15×), 10 *S. aureus* read sets were subsampled to low depths ([Methods](#Sec6){ref-type="sec"}). This confirmed that an average depth of only 10× was required for SRST2 to achieve \>90% call rate and \<0.5% false positives (Figure [3](#Fig3){ref-type="fig"}a, Figure [4](#Fig4){ref-type="fig"}). MLST databases can be expected to grow indefinitely due to increasing diversity and broader sampling. However simulations ([Methods](#Sec6){ref-type="sec"}) indicated that doubling the size of the *S. aureus* MLST database had no impact on SRST2 accuracy (Figure [3](#Fig3){ref-type="fig"}a, Figure [4](#Fig4){ref-type="fig"}).Figure 4**Accuracy of SRST2 allele calling at low read depths and with expanded MLST database size.** MLST analysis of public *S. aureus* data. (N = 10 read sets; each sampled 100 times to different depths; details in Methods). Tests were grouped by read depth and accuracy rates (y-axis, correct allele calls as a proportion of all tests), calculated at each depth (x-axis, red slashes indicate scale change from 1× to 10×). Red, real *S. aureus* MLST database; blue, expanded *S. aureus* MLST database (see [Methods](#Sec6){ref-type="sec"}); grey, unsampled data from five species mapped to real databases (as shown in Figures [1](#Fig1){ref-type="fig"} and [3](#Fig3){ref-type="fig"}).

Validation of gene detection using the vanA-B resistance gene {#Sec19}
-------------------------------------------------------------

In addition to reliably distinguishing alleles of a given gene, SRST2 can also accurately determine the presence or absence of genes of interest, such as those encoding antimicrobial resistance or virulence. To evaluate this, we used 43 *E. faecium* genomes (Table [1](#Tab1){ref-type="table"}), previously screened for vancomycin susceptibility and presence of the VanB vancomycin resistance operon *vanABHSXY* \[[@CR41],[@CR50]\]. Seventeen isolates were vancomycin resistant (VRE), and all were PCR positive for the *vanA-B* gene. These genomes were sequenced to approximately 1,000× depth and SRST2 correctly detected *vanA-B* in 17/17 VRE. In five vancomycin sensitive (VSE) isolates PCR negative for *vanA-B*, SRST2 detected *VanA-B* sequences at very low depths (\<0.2% of average depth), probably caused by minor but easily identifiable contamination during VRE-VSE multiplexed sequencing. SRST2 also confirmed the presence of the entire VanB operon, which is strongly predictive of the VRE phenotype. For comparison, assembly + BLAST identified full-length *vanA-B* sequences in just 7/17 VRE genomes, with multiple smaller hits spanning the full-length gene in five VRE and \<50% coverage of the gene identified in the remaining five VRE. To investigate the effect of sequencing depth on gene detection, we randomly selected five VRE and five VSE read sets for subsampling at \<10× average read depth. *VanA-B* was only ever detected in confirmed VRE genomes, and sensitivity of detection with SRST2 reached 100% for read sets with ≥5× average read depth (Figure [3](#Fig3){ref-type="fig"}c).

To further explore the relative sensitivity of gene detection with SRST2, we screened all the read sets used for MLST validation (Table [1](#Tab1){ref-type="table"}) for antimicrobial resistance genes in the ARG-Annot database of acquired resistance genes \[[@CR18]\] ([Methods](#Sec6){ref-type="sec"}). SRST2's detection of whole genes was more sensitive than detection of whole or partial gene sequences by assembly + BLAST (Figure [5](#Fig5){ref-type="fig"}): 6.8% of genes detected at ≥90% coverage by SRST2 at depths ≥15× were not found at ≥90% coverage in assemblies. For most of these genes, smaller fragments were detected by BLAST (Figure [5](#Fig5){ref-type="fig"}); however, SRST2 has the advantage of sensitive detection and confident allele-calling across the full length of genes, even at low depths (Figures [3](#Fig3){ref-type="fig"}c and [5](#Fig5){ref-type="fig"}). SRST2 also performed substantially better than the ResFinder website, which implements an alternative assembly + blast approach (Table [3](#Tab3){ref-type="table"}).Figure 5**Resistance gene detection. (a)** Venn diagram of antimicrobial resistance genes detected by SRST2 and assembly + BLAST, where the threshold for 'detection' of a gene is ≥90% coverage and ≥90% identity with a reference allele. No genes were detected by assembly + BLAST but not SRST2. **(b)** Distribution of average read depths per gene, calculated by SRST2 from mapped reads, for all genes detected by SRST2. **(c)** Coverage and nucleotide identity (%ID), as calculated by SRST2, for all genes detected by SRST2 but not by assembly + BLAST. **(d)** Impact of lowering the coverage threshold for detection of genes by BLAST (for those genes with ≥15× read depth).

Validation of SRST2 in a public health laboratory {#Sec20}
-------------------------------------------------

To validate SRST2 in a public health laboratory setting, we analysed 231 clinical isolates of *Listeria monocytogenes* and compared MLST data obtained from gold-standard PCR and amplicon sequencing with those obtained from SRST2 or assembly + BLAST analysis of Illumina MiSeq data (Figure [3](#Fig3){ref-type="fig"}b). Sequencing and analysis were performed by the Microbiological Diagnostic Unit Public Health Laboratory in Melbourne, Australia, the national reference laboratory for *L. monocytogenes*. For average read depths ≥15×, SRST2 had a substantially higher call rate than assembly-based analysis (99.6% vs. 95.7%; *P* \<1 × 10^-12^), with similar low false positive rates (0.7% vs. 0.6%; *P* = 0.9). Hence, for samples with ≥15× data, a total of 99% of all alleles were called correctly by SRST2, a significantly higher proportion than the 95% achieved by assembly + BLAST (*P* \<1 × 10^-12^). At \<15× read depths, SRST2 also performed better than assembly-based analysis (87% vs. 72% of alleles correctly called, respectively, *P* \<1 × 10^-3^; Figure [3](#Fig3){ref-type="fig"}b).

Further, SRST2 is already being assessed for routine MLST analysis of *Streptococcus pneumoniae* at Public Health England (Anthony Underwood, personal communication), and the open-source SRST2 code has been adapted by Public Health Ontario, Canada to perform specialist *emm* typing of Group A *Streptococcus* \[[@CR51]\].

Identification of antimicrobial resistant clones {#Sec21}
------------------------------------------------

In a hospital setting, the combination of MLST and gene detection can provide rapid and powerful insights for infection control without specialist bioinformatics knowledge. SRST2 analysis of 69 *K. pneumoniae* and 74 *E. coli* genomes from a UK hospital \[[@CR42]\] revealed that each was dominated by a single ST with a high rate of the extended-spectrum beta-lactamase (ESBL) gene CTX-M-15 (*K. pneumoniae* ST490 comprising 25% of total, 71% of ESBL; *E. coli* ST131 comprising 40% of total, 77% of ESBL; Figure [6](#Fig6){ref-type="fig"}). Routine SRST2 surveillance of ESBL infections could be indicative of hospital outbreaks and used to identify which isolates should be investigated via transmission analysis.Figure 6**SRST2 analysis of sequence types and beta-lactamase CTX-M-15 genes among hospital isolates.** Rates of isolation of different sequence types (STs), coloured by CTX-M-15 status, as determined by SRST2 run with default parameters on a public data set of strains from a single hospital. In each species, a single known ST dominates the population (highlighted) and is also the dominant source CTX-M-15 genes. '\*' next to an ST indicates a match to the closest defined ST; that is, that for all seven loci the closest known allele is the one belonging to that ST, however at ≥1 these loci there is an imprecise match (SNP or indel) compared to the known allele sequence. 'Novel' indicates a novel sequence type resulting from a combination of known alleles, with precise matches at all loci ('NF' in SRST2 output); 'Novel\*' indicates a novel combination of alleles, with ≥1 of those alleles being novel itself (that is, with no exact match in the MLST database) ('NF\*' in SRST2 output).

Using the *E. faecium* genome data, collected as part of a 12-year hospital study of vancomycin resistance \[[@CR41]\], SRST2 took approximately 30 min to generate the results and visualisations shown in Figure [7](#Fig7){ref-type="fig"}, indicating: (1) increasing vancomycin resistance over time; (2) a shift in dominant ST during the same period; and importantly (3) that this was not attributable to the introduction nor transmission of a new resistant clone, as the resistance rates were steady (approximately 50%) across all dominant STs. Similar conclusions typically require many days of labour and specialised assays in the diagnostic laboratory \[[@CR52]\] and have been confirmed by detailed WGS analysis showing frequent acquisition of VanB transposons by diverse circulating strains \[[@CR41]\].Figure 7**SRST2 analysis of** ***E. faecium*** **hospital data and hospital outbreak investigation.** Temporal distribution of isolates is shown in **(a)** coloured by vancomycin resistance as inferred from *vanA-B* detection with SRST2, and in **(b)** by coloured by sequence type inferred by SRST2. **(c)** Summary of all SRST2 results by sequence type (ST), in order from left to right: single linkage clustering of STs by number of shared alleles; MLST allele profiles; heatmap indicating the proportion of isolates that carries each resistance gene (scale as indicated), frequency of the ST (axis as indicated, coloured as in **(b)**).

Investigation of outbreaks and carbapenem resistance mechanisms {#Sec22}
---------------------------------------------------------------

We next applied SRST2 to analyse data from real-world small-scale infection control investigations \[[@CR15]\]. SRST2 took 5 min to generate results for suspected outbreaks of VRE and *E. cloaceae* (Figure [8](#Fig8){ref-type="fig"}), in which suspected outbreak isolates were readily distinguishable from epidemiologically unrelated isolates, consistent with WGS phylogenies and manual analysis of antimicrobial resistance markers \[[@CR15]\]. SRST2 typing of 18 plasmid replicons \[[@CR45]\] also indicated specific plasmid replicons (IncHI2, IncA/C) associated with two of the resistance profiles. The authors also reported use of a complex hybrid of assembly, mapping and manual inspection to determine carbapenem resistance mechanisms in five Gram-negative bacteria isolated in close proximity \[[@CR15]\]. SRST2 analysis of these five read sets identified the acquired beta-lactamases OXA-23 in AB223; IMP, SHV-12 and TEM-1 in EC1a; CTX-M-15 and TEM-1 in Eco216; CTX-M-15 and SHV-133 in KP652; and no acquired carbapenemase genes in EC302. These results are consistent with those reported from manual analysis \[[@CR15]\].Figure 8**SRST2 analysis of hospital outbreak investigation. (a)** Isolate genetic profiles obtained from SRST2 analysis, indicating that case EF4 was distinct in both sequence type and resistance gene profile from the outbreak cases EF2 and EF3. Full WGS analysis showed a similar result \[[@CR15]\]. **(b)** Isolate genetic profiles obtained from SRST2 analysis, including plasmid replicons detected (pink). The profiles indicate that case EC3 shared the same sequence type as the linked cases EC1 and EC2 (ST94), but lacked the IncA/C plasmid and had a distinct resistance gene profile. Full WGS analysis showed that EC1 and EC2 isolates were much closer to each other (≤22 SNPs) than to EC3 (\>150 SNPs) \[[@CR15]\].

Conclusions {#Sec23}
===========

Rapid and reliable extraction of clinically relevant genomic information will be essential for the adoption of WGS for infection control and public health surveillance. SRST2 was designed specifically to generate clinically informative genomic profiles of bacterial pathogens - encompassing sequence type, antibiotic resistance genes and virulence genes - direct from raw sequence data. It out-performs alternative approaches, including assembly-based approaches and our earlier mapping-based MLST software SRST, in terms of both speed and accuracy. Here we have validated the use of SRST2 for MLST of *L. monocytogenes* in a public health laboratory, and demonstrated its utility in the hospital setting for both infection control investigations and the identification of antibiotic resistance mechanisms.

Availability and requirements {#Sec24}
=============================

**Project name:** SRST2

**Project home page:**<http://katholt.github.io/srst2/>

**Operating system(s):** Platform independent

**Programming language:** Python

**Other requirements:** Python 2.7.5 or higher, Bowtie2 v2.1.0 or higher, and SAMtools 0.1.18.

**License:** BSD

**Any restrictions to use by non-academics:** None

Additional files {#Sec25}
================

Additional file 1**A CSV table listing the 543 read file accessions from these data sets together with the corresponding expected sequence types (STs), which were extracted from published results of PCR and capillary sequencing and used to assess accuracy of SRST2 allele calling (shown in Figure** [3](#Fig3){ref-type="fig"} **a).**Additional file 2**Separate plots for call rates and true positive rates for the six public data sets used for MLST allele typing validation (these two measures were combined to give the overall accuracy plot in Figure** [3](#Fig3){ref-type="fig"} **).**
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